Atlas Trials

A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease

Clinical trial NCT07431294 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07431294
Sponsor
Bayer
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Stable Coronary Artery Disease
Start date
2026-10-01
Primary completion
2027-05-07
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.